REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock Shares Outstanding

Quick Answer

REVIVA PHARMACEUTICALS HOLDINGS, INC. reported Common Stock Shares Outstanding of 5.87 million shares for the year ending 2025.

  • REVIVA PHARMACEUTICALS HOLDINGS, INC. showed an increase of +148.9% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from REVIVA PHARMACEUTICALS HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
  • XBRL data for this metric is available from 2019 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2019 to 2025), REVIVA PHARMACEUTICALS HOLDINGS, INC.'s Common Stock Shares Outstanding has grown by 125.7%.
  • Historical annual values: Fiscal year 2025: 5.87 million shares | Fiscal year 2024: 2.36 million shares | Fiscal year 2023: 27.92 million shares | Fiscal year 2022: 20.45 million shares | Fiscal year 2021: 14.43 million shares | Fiscal year 2020: 9.23 million shares | Fiscal year 2020: 9.23 million shares | Fiscal year 2020: 2.70 million shares | Fiscal year 2019: 2.60 million shares.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: